ROSENBLUM MARK J (Exec VP Finance, Interim CFO) purchased 223.8% of their position (76.25K shares) of DECOY THERAPEUTICS INC. on the open market
Open‑market purchase worth $29.8K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/9/2022ACC: 0001615219-22-000019
Officer· Exec VP Finance, Interim CFO
Since Sep 2019
+76.25K
Net shares
Net buyer
$29.8K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
76.25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+76.25K
Price / share
$0.39
Trade value
$29.81K
% of position
223.8%
3/3/2022
34.07K→110.32K
Total
Net shares
+76.25K
Net value
$29.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/3/2022 | P · Purchase | +76.25K | $0.39 | $29.81K | 223.8% | 34.07K | 110.32K |
| Total | +76.25K | $29.81K | ||||||
Derivative Transactions0
No derivative transactions reported